Cargando…
Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression
Autores principales: | Ma, Hong-Yu, Li, Yang, Yin, Hui-Zi, Yin, Hang, Qu, Yuan-Yuan, Xu, Qing-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565844/ https://www.ncbi.nlm.nih.gov/pubmed/37829327 http://dx.doi.org/10.1016/j.omtn.2023.102048 |
Ejemplares similares
-
TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression
por: Ma, Hong-Yu, et al.
Publicado: (2020) -
Retraction Note: MicroRNA-205-5p inhibits skin cancer cell proliferation and increase drug sensitivity by targeting TNFAIP8
por: Ge, Xinhong, et al.
Publicado: (2022) -
Retraction Notice to: LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells
por: Chen, Yunhao, et al.
Publicado: (2022) -
Retraction: Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
Publicado: (2022) -
Retraction Notice
Publicado: (2011)